SCHEMBL4617138

SCHEMBL4617138

CC(C)(C)OC(=O)NC1CCN(C(=O)c2ccc(N3CCCC3)nc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.53
CKS1B P61024 1/20 0.52
SKP1 P63208 1/20 0.52
SKP2 Q13309 1/20 0.52
HPGDS O60760 2/20 0.52
ALDH1A1 P00352 2/20 0.50
HSD17B10 Q99714 2/20 0.50
SFRP1 Q8N474 1/20 0.50
KDM4E B2RXH2 1/20 0.50
POLB P06746 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
ADRA1A P35348 4/20 0.49
AKT1 P31749 1/20 0.47
BTK Q06187 1/20 0.47
MAPK8 P45983 1/20 0.46
MAP4K4 O95819 2/20 0.46
PARP1 P09874 1/20 0.46
RET P07949 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6139979 0.95 ALDH1A1 (0.55) NAMPTCKS1BSKP1SKP2HPGDS
SCHEMBL4616966 0.85 EPHX2 (0.59) NAMPTCKS1BSKP1SKP2SFRP1
SCHEMBL6139645 0.85 CKS1B (0.61) NAMPTCKS1BSKP1SKP2HPGDS
SCHEMBL16049430 0.84 CKS1B (0.58) CKS1BSKP1SKP2HPGDSBTK
SCHEMBL16048031 0.84 CKS1B (0.60) NAMPTCKS1BSKP1SKP2HPGDS
SCHEMBL6139686 0.84 HRH3 (0.60) CKS1BSKP1SKP2HPGDSMAPK8
Lithium Ion SCHEMBL16048029 0.83 CKS1B (0.57) NAMPTCKS1BSKP1SKP2HPGDS
Lithium Ion SCHEMBL30026169 0.83 CKS1B (0.57) NAMPTCKS1BSKP1SKP2HPGDS
SCHEMBL4618959 0.83 NAMPT (0.55) NAMPTCKS1BSKP1SKP2AKT1
SCHEMBL12644375 0.83 NAMPT (0.70) NAMPTCKS1BSKP1SKP2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008061016-A1 N-SUBSTITUTED PIPERIDINYL 4 -ARYLSULFONAMIDES AS MODULATORS OF THE SECRETED FRIZZLED RELATED PROTEIN- 1 WYETH (US) 2008-05-22 WO disclosed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 NAMPT 3852/4885CKS1B 361/4885SKP1 350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.